Clinical Trial Update: Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study [NA]

View source ↗

Summary

A mechanistic study evaluating the effects of the Peptamen 1.6 nutritional formula in malnourished pancreatic cancer patients undergoing cephalic duodenopancrea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Peptamen 1.6 (Peptamen 1.6)

Snippet

Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Conditions: Pancreatic Cancer, Adult, Cephalic Duodenopancreatectomy | NA | Status: RECRUITING